🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 hora
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/08/2011 | 57,55 | 58,00 | 56,33 | 56,64 | -1,29% | 2,90% | 980.700 |
| 29/07/2011 | 56,85 | 57,88 | 56,06 | 57,38 | +1,07% | 3,20% | 1.169.000 |
| 28/07/2011 | 56,54 | 59,40 | 56,11 | 56,77 | +3,88% | 5,82% | 1.845.400 |
| 27/07/2011 | 55,62 | 55,99 | 53,87 | 54,65 | -2,22% | 3,81% | 778.400 |
| 26/07/2011 | 55,96 | 56,28 | 55,20 | 55,89 | -0,36% | 1,93% | 648.800 |
| 25/07/2011 | 56,46 | 56,58 | 55,79 | 56,09 | -1,04% | 1,40% | 530.400 |
| 22/07/2011 | 56,05 | 56,95 | 55,92 | 56,68 | +0,98% | 1,84% | 380.000 |
| 21/07/2011 | 55,28 | 56,52 | 54,88 | 56,13 | +2,00% | 2,97% | 696.100 |
| 20/07/2011 | 56,33 | 56,33 | 54,65 | 55,03 | -2,39% | 2,98% | 755.400 |
| 19/07/2011 | 56,14 | 56,91 | 55,89 | 56,38 | +0,99% | 1,82% | 827.000 |
| 18/07/2011 | 56,22 | 56,22 | 54,89 | 55,83 | -0,69% | 2,37% | 941.800 |
| 15/07/2011 | 56,35 | 56,55 | 54,90 | 56,22 | +0,05% | 2,93% | 1.594.700 |
| 14/07/2011 | 55,19 | 56,43 | 54,73 | 56,19 | +2,80% | 3,08% | 1.250.300 |
| 13/07/2011 | 55,01 | 55,70 | 54,48 | 54,66 | -0,15% | 2,22% | 805.200 |
| 12/07/2011 | 54,23 | 55,33 | 54,01 | 54,74 | +0,53% | 2,43% | 597.600 |
| 11/07/2011 | 54,96 | 55,08 | 54,09 | 54,45 | -1,59% | 1,80% | 550.300 |
| 08/07/2011 | 55,14 | 55,98 | 55,07 | 55,33 | -0,70% | 1,65% | 493.600 |
| 07/07/2011 | 55,35 | 56,06 | 54,65 | 55,72 | +1,05% | 2,55% | 634.500 |
| 06/07/2011 | 54,18 | 55,47 | 54,18 | 55,14 | +1,73% | 2,38% | 741.800 |
| 05/07/2011 | 55,41 | 55,72 | 53,89 | 54,20 | -2,66% | 3,30% | 982.800 |
| 01/07/2011 | 55,26 | 55,99 | 55,00 | 55,68 | +1,05% | 1,79% | 631.200 |
| 30/06/2011 | 54,73 | 55,61 | 54,64 | 55,10 | +0,60% | 1,77% | 925.800 |
| 29/06/2011 | 54,39 | 55,02 | 53,96 | 54,77 | +0,31% | 1,95% | 747.800 |
| 28/06/2011 | 53,66 | 54,86 | 53,50 | 54,60 | +2,08% | 2,53% | 1.324.100 |
| 27/06/2011 | 53,66 | 53,96 | 53,14 | 53,49 | -1,05% | 1,53% | 1.220.900 |
| 24/06/2011 | 54,30 | 54,81 | 53,44 | 54,06 | -0,59% | 2,52% | 1.322.400 |
| 23/06/2011 | 53,56 | 54,58 | 53,20 | 54,38 | +0,97% | 2,58% | 1.049.800 |
| 22/06/2011 | 54,18 | 54,54 | 53,66 | 53,86 | -0,77% | 1,62% | 1.377.800 |
| 21/06/2011 | 53,93 | 54,42 | 53,38 | 54,28 | +0,99% | 1,93% | 1.424.200 |
| 20/06/2011 | 54,41 | 54,76 | 53,44 | 53,75 | -1,18% | 2,43% | 1.115.700 |